BMX-010

DRUG3 trials

Sponsors

BioMimetix JV, LLC

Conditions

Atopic DermatitisPsoriasisRosacea

Phase 2

Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis

CompletedNCT03381625

BioMimetix JV, LLCAtopic Dermatitis, Psoriasis

Start: 2018-01-02End: 2021-07-24Updated: 2021-10-05

Evaluation of Topical Application of BMX-010 in Subjects With Rosacea

SuspendedNCT03756389

BioMimetix JV, LLCRosacea

Start: 2018-01-03End: 2025-03-31Target: 60Updated: 2022-09-28

A Clinical Trial of BMX-010 in Adult Subjects With Atopic Dermatitis

TerminatedNCT05491447

BioMimetix JV, LLCAtopic Dermatitis

Start: 2023-01-08End: 2024-04-15Updated: 2024-04-18